Aytu Biopharma (AYTU) Restructuring Costs (2020 - 2024)

Aytu Biopharma (AYTU) has 3 years of Restructuring Costs data on file, last reported at $1.3 million in Q4 2024.

• Restructuring Costs for Q4 2024 came in at $1.3 million, changed N/A year-over-year; the trailing twelve-month figure through Sep 2025 was $1.3 million (down 55.2% YoY), and the FY2025 annual result was $2.1 million, down 2.55% from the prior year.
• Restructuring Costs climbed to $1.3 million in Q4 2024 per AYTU's latest filing, from $784000.0 in the prior quarter.
• Over five years, Restructuring Costs peaked at $2.9 million in Q1 2021 and troughed at $70000.0 in Q2 2021.
• A 3-year average of $1.1 million and a median of $814277.0 in 2020 frame the typical range for Restructuring Costs.
• On a YoY basis, Restructuring Costs climbed as much as 832.23% in 2021 and fell as far as 91.4% in 2021.
• A 3-year view of Restructuring Costs shows it stood at $1.3 million in 2020, then tumbled by 94.66% to $70000.0 in 2021, then soared by 1781.43% to $1.3 million in 2024.
• Business Quant data shows AYTU's Restructuring Costs at $1.3 million in Q4 2024, $784000.0 in Q3 2024, and $1.9 million in Q2 2024.